3 biotech winners for 2006 Peptech:target 2.25, 3 mos
Bta : target 3 after Glaxo trial
SRX : Sirtex target $3 short term, $6-7 medium term after large reveunue and profit expansion wnd widespread apllicability of Sir spheres to treat many different metastases to liver with many different chemotherapeutics already underway
- Forums
- ASX - General
- australias top management teams
3 biotech winners for 2006 Peptech:target 2.25, 3 mosBta :...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)